| Literature DB >> 16258197 |
Joanna Narbutt1, Aleksandra Lesiak, Malgorzata Skibinska, Anna Wozniacka, Anna Sysa-Jedrzejowska, Joalanta Lukamowicz, Henk van Loveren.
Abstract
The aim of our study was to compare serum concentration of IL-1beta, IL-6, IL-8, IL-10, and TNF-alpha in 105 healthy volunteers before and after exposure to UVR: 25 subjects (10 days of UVB), 55 (10 days of UVB or solar-simulated radiation, followed by acute UVB dose), and 25 (local high dose of UVB). In all the individuals blood samples were analyzed before and after final irradiation by chemiluminescence assay. After 10 days of UVB irradiation a statistically significant increase in serum concentration only in IL-8 (P<.05) and strong tendency in TNF-alpha (P=.05) were observed. The applied schedules of irradiation have minor impact on serum cytokine level and still a threshold dose of UVR causing systemic immune impairment is unknown.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16258197 PMCID: PMC1533891 DOI: 10.1155/MI.2005.298
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Clinical characteristics of studied volunteers. F denotes female; M denotes men; and MED denotes minima erythema dose.
| Group | Number of subjects | Gender F/M | Mean age | Phototype II/III | Mean MED (J/cm2) |
| A | 25 | 12/13 | 31 | 12/13 | 0.16 |
| B | 30 | 16/14 | 27.7 | 8/22 | 0.15 |
| C | 25 | 13/12 | 25 | 14/11 | 0.14 |
| D | 25 | 13/12 | 29.5 | 16/9 | 0.14 |
Serum concentrations of selected cytokines in all examined groups. N is the number of volunteers, D detectable level, MED minimal erythema dose, UVB ultraviolet radiation B, and SSR solar-simulated radiation.
| Group | Cytokines (pg/mL) | ||||
| IL-6 | IL-8 | IL-10 | TNF- | ||
| D | D | D | D | ||
| (range) | (range) | (range) | (range) | ||
| A | Before UVB | N = 5 | N = 4 | N = 1 | N = 23 |
| (2.14–6.86) | (5.02–9.46) | (12.0) | (4.04–10.5) | ||
| After 10 days of 0.7 | N = 9 | N = 9 | N = 1 | N = 20 | |
| MED UVB | (2.01–7.45) | (5.09–8.78) | (14.5) | (4.04–10.5) | |
| B | Before UVB | N = 2 | N = 9 | N = 1 | N = 21 |
| (2.43; 6.84) | (5.0–9.51) | (15.5) | (4.12–9.79) | ||
| After 10 days of 0.7 | N = 3 | N = 16 | N = 1 | N = 23 | |
| MED UVB | (2.89–6.9) | (5.12–14.0) | (29.8) | (4.03–10.1) | |
| After 3 MED | N = 3 | N = 10 | N = 0 | N = 23 | |
| UVB | (2.88–6.9) | (5.2–25.6) | (4.04–8.56) | ||
| C | Before SSR | N = 6 | N = 9 | N = 1 | N = 23 |
| (2.03–3.59) | (5.01–7.9) | (11.7) | (4.79–16.9) | ||
| After 10 days of 1.2 | N = 3 | N = 3 | N = 2 | N = 18 | |
| SED SSR | (2.47–9.1) | (6.59–7.3) | (10.4; 15.5) | (4.14–24.3) | |
| After 3 | N = 4 | N = 6 | N = 2 | N = 19 | |
| MED UVB | (2.06–7.9) | (5.31–8.78) | (8.38; 12.2) | (4.14–19.0) | |
| D | Before UVB | N = 4 | N = 7 | N = 2 | N = 23 |
| (2.31–3.6) | (5.01–7.58) | (7.11; 9.35) | (4.47–9.66) | ||
| After 3 MED | N = 2 | N = 7 | N = 3 | N = 19 | |
| UVB | (2.88; 4.58) | (5.02–8.02) | (5.6–8.67) | (4.22–8.88) | |